{
  "query": "Alzheimer",
  "resolved": null,
  "signals": [
    {
      "type": "hot_area",
      "headline": "\"Alzheimer\" heating up — 8 grants ($219,644,270), 34 active trials (13 started <12 mo)",
      "entity": "Alzheimer",
      "ticker": null,
      "upstream": {
        "event": "NIH grant velocity",
        "detail": "8 grants, $219,644,270 in window"
      },
      "observed": {
        "event": "Trial velocity",
        "detail": "34 trials, 13 newly started"
      },
      "predicted": {
        "event": "Elevated M&A / licensing / IPO activity in this mechanism over 12–24 mo",
        "leadTime": "12–24 mo",
        "note": "Funding+trial co-velocity historically precedes BD activity; directional only."
      },
      "leadTime": "12–24 mo to BD/commercial activity (directional)",
      "confidence": 0.5,
      "sponsors": [
        "Massachusetts General Hospital",
        "University of California, Los Angeles",
        "Eli Lilly and Company",
        "Lighthouse Pharmaceuticals, Inc.",
        "National Institute of Mental Health (NIMH)",
        "Centre Hospitalier Universitaire de Nice",
        "Vanderbilt University Medical Center",
        "Johns Hopkins University"
      ]
    }
  ],
  "recentFilings": null,
  "disclaimer": "Research/informational. NOT investment advice.",
  "generatedAt": "2026-06-21T09:50:25.029Z"
}